CliffBio
small molecule

APREPITANT

APREPITANT

Loss of exclusivity—loss of exclusivity
CompanyGLENMARK SPECIALTY SA

Drug detail

Brand nameAPREPITANT
Active ingredientAPREPITANT
Strength80MG
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 2017
Marketing statusRX

More from GLENMARK SPECIALTY SA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

APREPITANT patent cliff — loss of exclusivity — | CliffBio